Dr. Mary Claire Haver: What We Need To Know About Hormone Replacement Therapy

Why It Matters

Increasing HRT adoption empowers women’s health decisions and drives growth in a previously under‑served pharmaceutical market.

Key Takeaways

• Women should decide HRT after informed risk-benefit discussion.
• HRT perceived risks have limited usage to 4% of women.
• Recent data shows HRT safety and efficacy improving.
• Demand for FDA‑approved HRT is rising, causing shortages.
• Certified practitioners essential for personalized hormone therapy decisions.

Summary

Dr. Mary Claire Haver argues that hormone replacement therapy (HRT) should be a patient‑driven choice, with clinicians providing clear risk‑benefit information rather than gatekeeping. She likens the decision‑making process to that afforded to men regarding testosterone, emphasizing autonomy over paternalism.

The talk highlights that only about 4 % of women were on FDA‑approved HRT in 2023, reflecting lingering safety concerns. Haver points out that modern studies demonstrate the therapy’s safety profile and therapeutic benefits, prompting a shift in medical opinion and a growing willingness to prescribe appropriate doses for shorter durations.

She quotes, “You can throw your opinion in there, but it’s not my decision to tell a woman what to do with her own body,” underscoring the ethical stance. The rising demand has already created supply shortages, indicating that more women are seeking qualified practitioners for personalized regimens.

The trend suggests a market expansion for HRT products and a need for more trained providers. Greater adoption could improve quality of life for menopausal women while reshaping pharmaceutical supply chains and insurance coverage policies.

Original Description

Dr. Mary Claire Haver shared that as of 2023, only 4% of women are on FDA-approved HRT. That number says a lot about how little support and information women have had around perimenopause. And thankfully that’s starting to change.

For our full conversation, listen to the Good Inside Podcast wherever you get your podcats.